Dados B3 › RVEE3 × RADL3
RVEE3 × RADL3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | RVEE3 | RADL3 | year |
|---|---|---|---|
| ROE | 0.0%! | 18.9% | 2025 |
| ROIC | 23.7%! | 24.8% | 2025 |
| ROA | 14.1%! | 5.5% | 2025 |
| Gross margin | -421.1% | 29.3% | 2025 |
| EBIT margin | 2,199.6%! | 6.2% | 2025 |
| Net margin | 1,061.9% | 2.9% | 2025 |
| Net debt/EBITDA | — | 0.69x | no year where both have it |
| Current ratio | 4.15x | 1.46x | 2025 |
| Revenue growth (1y) | — | 13.8% | no year where both have it |
| Revenue growth (5y CAGR) | — | 17.1% | no year where both have it |
| Piotroski F-Score | 1/9! | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | RVEE3 | RADL3 | year |
|---|---|---|---|
| P/E | — | 32.24x | 2025 |
| P/B | 0.94x | 5.71x | 2025 |
| EV/EBITDA | — | 9.37x | 2025 |
| FCF yield | — | 2.5% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 14:42 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 14:42 UTC. If this does not match /saude, you are reading a cached copy.